Stefano Ursino

University of Pisa

Papers

1

Total Citations

1

H-Index

1

About

Stefano Ursino’s research centers on head and neck oncology, with a particular focus on HPV-mediated oropharyngeal squamous cell carcinoma and the comparative effectiveness of surgical versus non-surgical treatment modalities. His major contribution lies in evaluating oncologic outcomes—including overall survival, disease-free survival, and quality of life—for patients with p16+ oropharyngeal cancer treated with upfront trans-oral robotic surgery (TORS) versus radiotherapy or chemoradiotherapy. This work directly informs clinical decision-making by weighing the benefits of minimally invasive surgery against radiation-based approaches, offering nuanced insights into patient-centered care. While his most-cited paper (2024) currently has 1 citation, its recent publication signals emerging impact in a rapidly evolving field. Ursino’s research is notable for integrating survival metrics with quality-of-life assessments, a holistic perspective that resonates with both surgeons and oncologists. His work contributes to the growing evidence base for de-escalation strategies in HPV-positive disease, aiming to reduce treatment toxicity without compromising oncologic control. For students and researchers, Ursino exemplifies how comparative effectiveness research can bridge surgical and radiation oncology, guiding personalized treatment pathways.

Research Focus

Key Achievements

1
H-Index
1
Papers
1
Total Citations
1
Avg Citations/Paper
🏆 Most Cited Paper
Overall survival, disease-free survival and quality of life in patients affected by HPV mediated p16+ oropharyngeal squamous cell carcinoma treated with upfront trans-oral robotic surgery vs radiotherapy or chemoradiotherapy
1 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Pisa

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago